Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03419416
Other study ID # 201523748
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 24, 2017
Est. completion date June 30, 2019

Study information

Verified date July 2019
Source Addis Ababa University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The main objective is to implement Kangaroo Mother Care (KMC) at selected facilities in Addis Ababa and Oromia Regions to achieve high effective coverage in the catchment population.


Description:

To achieve the objective summarized above, the investigators will engage in an iterative process using program learning and quantitative data to continuously improve models in order to enhance uptake of KMC in two phases.

In phase 1, the model will undergo an iterative process whereby every three months, the investigators will analyze the data collected and improve the model until it is reached at a model that achieves effective KMC coverage of at least 80%.

In phase 2, we will scale the successful model to all selected facilities.

The investigators' primary outcomes will be effective coverage of KMC at 7 days of age, and effective coverage of KMC at 7 days after discharge from the facility. Effective coverage will be defined as adoption of skin to skin care for at 8 least hours and exclusive breastfeeding in the 24 hours prior to assessment


Recruitment information / eligibility

Status Completed
Enrollment 700
Est. completion date June 30, 2019
Est. primary completion date June 30, 2019
Accepts healthy volunteers No
Gender All
Age group N/A to 28 Days
Eligibility Inclusion Criteria:

- All newborns who are less than 2000 gm born within the study facilities during the study period.

Exclusion Criteria:

- Newborns who are sick per predefined criteria will not be provided KMC until they have been stabilized. Criteria for delay of initiation include: critical illness including apnea, decreased respiratory rate <20 breaths per minute, grunting, cyanosis, severe chest in-drawing, convulsions, unconsciousness, and severe hypothermia <32°F.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Kangaroo mother care (KMC)
Skin to skin contact of newborns with mothers and exclusive breast feeding

Locations

Country Name City State
Ethiopia Batu Hospital Adami Tulu Oromia
Ethiopia Tirunesh Beijing Hospital Akaki Addis Ababa

Sponsors (3)

Lead Sponsor Collaborator
Addis Ababa University Harvard School of Public Health, World Health Organization

Country where clinical trial is conducted

Ethiopia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Effective coverage of KMC at 7 days of age. Effective coverage will be defined as adoption of skin-to-skin care for at least 8 hours and exclusive breastfeeding in the 24 hours prior to assessment. Seven days of age
See also
  Status Clinical Trial Phase
Completed NCT05087160 - Socioeconomic Inequalities Exacerbated by Mitigation Measures to COVID-19 and Differences in Prematurity Prevalence